5 Cancer Research Stories Worth Following – Summer 2016

Cancer research stories worth following this summer include a study on extending the use of aromatase inhibitors in the treatment of hormone receptor-positive breast cancer.What’s exciting in cancer research right now? In this post, I’ll review several of the most interesting cancer research stories that have been in the news this summer.

These are a few of the recent stories that seem to have the greatest potential impact, at least from my perspective, and that I know I’ll want to follow as they develop further.

Stories worth following include several studies presented at the annual meeting of the American Society of Clinical Oncology (ASCO) in June.  Among those were a study on extending the use of aromatase inhibitors in breast cancer treatment; findings that a web app boosts survival for patients with lung cancer; and, research on the use of a “biosimilar” treatment that can substitute for the breast cancer drug Herceptin. Continue reading

6 Cancer Research Stories Worth Following – Winter 2015

Cancer research news in early 2015 included first-time FDA approvals of drugs in several new categories.What’s exciting in cancer research right now? In this post, I’ll briefly review several notable cancer research stories that have come out over the last two to three months.

These are a few of the recent stories that seem to have the greatest potential impact, at least from my perspective, and that I know I’ll want to follow as they continue to unfold.

Some of the topics covered this time include targeted therapies, reducing treatment toxicities and triple negative breast cancer.

Continue reading